Xifeng Lu

2.2k total citations · 1 hit paper
54 papers, 1.7k citations indexed

About

Xifeng Lu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Xifeng Lu has authored 54 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 15 papers in Cardiology and Cardiovascular Medicine and 14 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Xifeng Lu's work include Renin-Angiotensin System Studies (14 papers), Hormonal Regulation and Hypertension (13 papers) and Receptor Mechanisms and Signaling (8 papers). Xifeng Lu is often cited by papers focused on Renin-Angiotensin System Studies (14 papers), Hormonal Regulation and Hypertension (13 papers) and Receptor Mechanisms and Signaling (8 papers). Xifeng Lu collaborates with scholars based in China, Netherlands and United States. Xifeng Lu's co-authors include A.H. Jan Danser, Zhaokui Jin, Qianjun He, Danyang Chen, Penghe Zhao, Yang Tian, Qian Chen, Zhen Gu, Meng Jin and Zac Varghese and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Molecular Cell.

In The Last Decade

Xifeng Lu

49 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Local generation of hydrogen for enhanced photothermal therapy

2018 323 citations Penghe Zhao, Zhaokui Jin et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xifeng Lu China	23	663	334	309	299	299	54	1.7k
Feng Wu China	27	726 1.1×	152 0.5×	179 0.6×	106 0.4×	313 1.0×	85	2.0k
Xi Cao China	24	614 0.9×	185 0.6×	198 0.6×	214 0.7×	326 1.1×	70	1.7k
Tingzhong Wang China	26	1.0k 1.5×	473 1.4×	279 0.9×	95 0.3×	251 0.8×	75	2.0k
Shyam S. Bansal United States	23	895 1.3×	817 2.4×	280 0.9×	84 0.3×	260 0.9×	56	2.3k
Di Yang China	28	872 1.3×	479 1.4×	117 0.4×	101 0.3×	326 1.1×	88	1.9k
Chen Fang China	24	567 0.9×	101 0.3×	212 0.7×	239 0.8×	120 0.4×	77	1.4k
Jiancheng Guo China	20	571 0.9×	86 0.3×	129 0.4×	335 1.1×	214 0.7×	41	1.9k
Young‐Kyo Seo South Korea	30	1.0k 1.6×	82 0.2×	316 1.0×	237 0.8×	172 0.6×	59	2.4k
Kyung Chan Park South Korea	25	812 1.2×	294 0.9×	181 0.6×	115 0.4×	128 0.4×	45	2.3k
Takuma Aoyama Japan	19	790 1.2×	367 1.1×	374 1.2×	139 0.5×	97 0.3×	33	2.9k

Countries citing papers authored by Xifeng Lu

Since Specialization

Citations

This map shows the geographic impact of Xifeng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xifeng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xifeng Lu more than expected).

Fields of papers citing papers by Xifeng Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xifeng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xifeng Lu. The network helps show where Xifeng Lu may publish in the future.

Co-authorship network of co-authors of Xifeng Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Xifeng Lu. A scholar is included among the top collaborators of Xifeng Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xifeng Lu. Xifeng Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sun, Yuan, Xifeng Lu, & Maolin Wang. (2024). The different functions of V-ATPase subunits in adipocyte differentiation and their expression in obese mice. Biochemical and Biophysical Research Communications. 733. 150733–150733.

Tan, Lunbo, Na Wang, Monique Mulder, et al.. (2024). Statins, but not proprotein convertase subtilisin‐kexin type 9 inhibitors, lower chemerin in hypercholesterolemia via low‐density lipoprotein receptor upregulation. SHILAP Revista de lepidopterología. 5(9). e681–e681.

Tan, Lunbo, Michelle Broekhuizen, Zhongli Chen, et al.. (2024). Statins Prevent the Deleterious Consequences of Placental Chemerin Upregulation in Preeclampsia. Hypertension. 81(4). 861–875. 14 indexed citations

Wang, Shujin, Mengqian Hou, Dietbert Neumann, et al.. (2024). Glycolysis-Mediated Activation of v-ATPase by Nicotinamide Mononucleotide Ameliorates Lipid-Induced Cardiomyopathy by Repressing the CD36-TLR4 Axis. Circulation Research. 134(5). 505–525. 16 indexed citations

Dong, Shaowei, Jiayan Chen, Huahui Li, et al.. (2024). ATP6V0A1-dependent cholesterol absorption in colorectal cancer cells triggers immunosuppressive signaling to inactivate memory CD8+ T cells. Nature Communications. 15(1). 5680–5680. 19 indexed citations

Tan, Lunbo, Na Wang, Jeanine E. Roeters van Lennep, et al.. (2023). Statins, but not PCSK9 inhibitors, reduce the adipokine chemerin in familial hypercholesterolemia: Focus on lipoprotein subfractions. Atherosclerosis. 379. S173–S173. 1 indexed citations

Tan, Lunbo, Xifeng Lu, A.H. Jan Danser, & Koen Verdonk. (2023). The Role of Chemerin in Metabolic and Cardiovascular Disease: A Literature Review of Its Physiology and Pathology from a Nutritional Perspective. Nutrients. 15(13). 2878–2878. 30 indexed citations

Tan, Lunbo, Zijun Ouyang, Zhilong Chen, et al.. (2023). Adipokine chemerin overexpression in trophoblasts leads to dyslipidemia in pregnant mice: implications for preeclampsia. Lipids in Health and Disease. 22(1). 12–12. 8 indexed citations

Hou, Tianyun, Yuan Tian, Ziyang Cao, et al.. (2022). Cytoplasmic SIRT6-mediated ACSL5 deacetylation impedes nonalcoholic fatty liver disease by facilitating hepatic fatty acid oxidation. Molecular Cell. 82(21). 4099–4115.e9. 66 indexed citations

10.

Sun, Yuan, Lunbo Tan, Michelle Broekhuizen, et al.. (2021). Megalin, Proton Pump Inhibitors and the Renin–Angiotensin System in Healthy and Pre-Eclamptic Placentas. International Journal of Molecular Sciences. 22(14). 7407–7407. 7 indexed citations

11.

Bovée, Dominique M., Liwei Ren, Estrellita Uijl, et al.. (2021). Renoprotective Effects of Small Interfering RNA Targeting Liver Angiotensinogen in Experimental Chronic Kidney Disease. Hypertension. 77(5). 1600–1612. 22 indexed citations

12.

Ye, Dien, Xiaofei Yang, Liwei Ren, et al.. (2021). (Pro)renin Receptor Inhibition Reduces Plasma Cholesterol and Triglycerides but Does Not Attenuate Atherosclerosis in Atherosclerotic Mice. Frontiers in Cardiovascular Medicine. 8. 725203–725203. 5 indexed citations

13.

Ling, Rongsong, et al.. (2020). In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2. Peptides. 130. 170328–170328. 89 indexed citations

14.

Ren, Liwei, Xifeng Lu, & A.H. Jan Danser. (2019). Revisiting the Brain Renin-Angiotensin System—Focus on Novel Therapies. Current Hypertension Reports. 21(4). 28–28. 42 indexed citations

15.

Zhao, Penghe, Zhaokui Jin, Qian Chen, et al.. (2018). Local generation of hydrogen for enhanced photothermal therapy. Nature Communications. 9(1). 4241–4241. 323 indexed citations breakdown →

16.

Yang, Xiaochun, Daryl M. Okamura, Xifeng Lu, et al.. (2017). CD36 in chronic kidney disease: novel insights and therapeutic opportunities. Nature Reviews Nephrology. 13(12). 769–781. 198 indexed citations

17.

Sun, Yuan, A.H. Jan Danser, & Xifeng Lu. (2017). (Pro)renin receptor as a therapeutic target for the treatment of cardiovascular diseases?. Pharmacological Research. 125(Pt A). 48–56. 17 indexed citations

18.

Lu, Xifeng, et al.. (2014). Renin inhibitor VTP-27999 differs from aliskiren. Journal of Hypertension. 32(6). 1255–1263. 1 indexed citations

19.

Lu, Xifeng, et al.. (2013). The intrarenal renin-angiotensin system: does it exist? Implications from a recent study in renal angiotensin-converting enzyme knockout mice. Nephrology Dialysis Transplantation. 28(12). 2977–2982. 14 indexed citations

20.

Lu, Xifeng. (2011). HRP and prorenin: focus on the (pro)renin receptor and vacuolar H+-ATPase. Frontiers in Bioscience-Scholar. S3(1). 1205–1205. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact